The organizing committee of the 52nd Annual Scientific Meeting of the Japan Atherosclerosis Society encourages abstract submission widely from overseas.
All the abstracts submitted are rated and selected for presentation by the organizing committee.
Thursday, December 12, 2019 to Thursday, January 23, 2020
extended until Monday, February 10 at 12:00 (JST)
Abstract submission is closed.
Thank you for your submission.
Submissions, modifications, or deletions of abstracts will not be accepted after the deadline. Traffic to the site is expected to be heavy close to the deadline, which may cause a delay in processing the submission of your abstract. You are recommended to submit abstracts as early as possible.
Abstract contents submitted online may be modified until the deadline. Please note that you may not be able to make modifications just before the deadline if traffic is heavy.
Changes, such as to the names of co-authors, after the deadline will not be accepted. Please be sure to include those corrections during the abstract submission period.
Thursday, December 12, 2019 to Wednesday, January 15, 2020
Abstract Submission is closed.
If you want to apply for a grant, please click “Grant for participants from overseas” in the online abstract submission system.
The applicants from overseas affiliations will be evaluated from the abstract, and the awards will be granted to the ten most outstanding researches on the atherosclerosis. A selected applicant will receive a grant (from JPY125,000 to JPY200,000, depending on the location of the country).
A disclosure statement of conflict of interest (COI) must be submitted along with the abstract. It is the author's responsibility to report any real or perceived financial conflict of interest. Any potential for financial gain that may be derived from reported work may constitute a potential conflict of interest. Disclosure is required in any case in which an individual or company stands to benefit financially from research performed. Therefore, the onus is on each author to disclose any financial benefit to an individual or company.
For Questions regarding COI disclosure
Japan Atherosclerosis Society E-mail: firstname.lastname@example.org
Click on the button below to download the COI Disclosure Statement.
Save the downloaded COI Disclosure Statement to your desktop. Change the file name to “52JAS_COI (Presenter’s LAST NAME FIRST NAME)
Open the COI Disclosure Statement saved to your desktop and fill in the necessary items.
* Even if you have no potential conflicts of interest, please check the “No” box. Save the COI Disclosure Statement in which you have included the necessary items.
* This COI Disclosure Statement will be uploaded later.
Fill in all required items on the Abstract Submission page.
After filling in the information, click the “Proceed to submit” button displayed at the bottom of the page.
A confirmation page showing the information on your submission will be displayed. Confirm that there are no mistakes in the submission contents and click the “Submit (登録)” button displayed at the bottom of the page.
Your “Registration Number” and “Password for Reference/Updates” will be displayed. Print out this page to save your information.
* Please do not close the screen. You will upload the COI Disclosure Statement from this screen.[How to upload the chart or diagram]
Click on the “Upload Document (論文ファイルアップロード)” button at the bottom of the screen. (The “COI (Conflict of Interest) File Submission” screen to upload the COI Disclosure Statement created in STEP 1 will be displayed.)
Click the “Browse” or “Select File (参照)” button. (The name of the button may differ depending on the browser used.)
Select the COI Disclosure Statement created in STEP 1 from the file selection screen.
Click the “Start Upload (アップロード開始)” button.
Check that the “Upload Completed Successfully (アップロードは正常に終了しました)” window is displayed.
* If this is displayed on your screen, the COI Disclosure Statement has been uploaded.
|01||Basic research||Vascular biology・Angiogenesis|
|05||Animal experiments・Model animal|
|06||Thrombosis and hemostasis・Coagulation and fibrinolysis|
|09||Diabetes・Endocrine disorders・Metabolic syndorome・Obesity|
|15||Lipoprotein metabolism・Lipoprotein receptor|
|16||Reverse cholesterol transport system・HDL Function|
|17||Lipid absorption and postprandial lipemia|
|20||Dyslipidemia・atherosclerosis in women and children|
|21||Dyslipidemia and examination|
|Diet therapy/Nutritional therapy/Functional food|
|25||Drug therapy・Antibody drugs|
|Epidemiological study・Observational studies|
|28||Image inspection・Imaging・Vascular function evaluation|
|29||Acute coronary syndrome・Angina|
|31||Cerebrovascular disease・Vascular dementia|
|33||Medical checkup・Preventive medicine・Industrial and labor hygiene|
|35||Medical staff session||Industrial hygiene・Health care・Preventive medicine|
You may be asked to deliver your presentation in a category that is different from the one you specified when submitting your abstract, depending on the program setup. Thank you for your understanding.
The following browsers can be used with this abstract submission system.
When submitting an abstract for the first time, registrants will need to decide on an optional password.
After the submission of your abstract is complete, a registration number (10000 series) will be issued automatically. The submission process for the abstract is complete when this registration number is issued (A message confirming registration will be sent.). If the registration number does not appear on the screen, the submission has not been received.
Use the confirmation/modification button to make corrections to submitted abstracts. You can modify and check the abstract as many times as you like by entering the registration number and your password until the submission period deadline. You may also delete your submission. Note that if you click the new “Submit (登録)” button each time you modify the contents, there will be duplicate submissions of the same abstract.
Registrants must keep a record of the registration number and password issued to them. We will not respond to inquiries about registration numbers or passwords to prevent browsing and misuse by third parties.
There have been many cases where emails from Organizer or Secretariat of this Meeting have been sent to “Junk” folders. If you believe that you have not received a message from us, check the Junk folder first. If you have a “Spam Mail Folder” on your WEB mail account, in addition to your mail software’s Junk mail folder, check that as well.
|Superscripts||Enclose the beginning and end of text with <SUP> and </SUP>||Na<SUP>＋</SUP>||Na＋|
|Subscript||Enclose the beginning and end of text with <SUB> and </SUB>||H<SUB>2</SUB>O||H2O|
|Italics||Enclose the beginning and end of text with <I> and </I>||<I>c-fos</I>||c-fos|
|Bold||Enclose the beginning and end of text with <B> and </B>||<B>Bold</B>||Bold|
|Underline||Enclose the beginning and end of text with <U> and </U>||<U>Underline</U>||Underline|
* The personal information registered will not be used for any purposes other than for the preparation of the 52nd Annual Scientific Meeting of the Japan Atherosclerosis Society. We will take the necessary security measures to strictly protect the personal information registered.
Upload the COI Disclosure Statement again if you wish to modify (update) the COI. Create and save the modified (updated) COI Disclosure Statement.
* When the upload is complete, the COI Disclosure Statement will be saved as the new version.
c/o Congress Corporation
Daiichi seimei Bldg., 2-13 Shinsakae-machi Naka-ku, Nagoya 460-0004 Japan
Phone: +81-52-950-3369 Fax: +81-52-950-3370